Combined BRAF(V600E) and MEK blockade for BRAF(V600E)-mutant gliomas

BRAF(V600E) is a common finding in glioma (about 10–60% depending on histopathologic subclassification). BRAF(V600E) monotherapy shows modest preclinical efficacy against BRAF(V600E) gliomas and also induces adverse secondary skin malignancies. Here, we examine the molecular mechanism of intrinsic r...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurooncol
Egile Nagusiak: Zhang, Jie, Yao, Tsun-Wen, Hashizume, Rintaro, Hariono, Sujatmi, Barkovich, Krister J., Fan, Qi-Wen, Prados, Michael, James, C. David, Weiss, William A., Nicolaides, Theodore
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5560871/
https://ncbi.nlm.nih.gov/pubmed/27848137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-016-2333-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak